Lasers used for painless injections; RXi and Royal Philips ink delivery pact;

CNET reviews Pantec's new Painless Laser Epidermal System, which uses lasers to create micropores in the skin, doing away with injections. Medical professionals can adjust the delivery device for diabetics to use at home, and there's a desktop unit that can be used in the clinic for faster injections. Story

> RXi and Royal Philips are partnering, matching RXi's RNAi compounds with Royal's ultrasound tech to monitor and deliver the compounds. Report

> ULURU, which is working on the improved delivery of a portfolio of wound management and oral care products, announced the resignation of CEO Renaat Van den Hooff. Release

> Hospira has inked a licensing pact with Durect for Posidur, a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials. Release

> The drug delivery specialist Vectura says it is closing in on a pact to market its generic asthma drug in the U.S. The U.K. developer also said it has three new products being readied for the clinic. Report

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.